Acid reflux drugs may have negative side effects for breast cancer survivors

by Emily Caldwell,The Ohio State UniversityAcid reflux drugs that are sometimes recommended to ease stomach problems during cancer treatment may have an unintended side effect: impairment of bre

Updated on: December 23,2023

Acid reflux drugs may have negative side effects for breast cancer survivors

by Emily Caldwell,The Ohio State UniversityAcid reflux drugs that are sometimes recommended to ease stomach problems during cancer treatment may have an unintended side effect: impairment of bre

Updated on:December 23,2023

Warning for younger women: Be vigilant on breast cancer risk

Updated on: November 04,2024

Warning for younger women: Be vigilant on breast cancer risk

Updated on:November 04,2024

Faster genomics-based diagnosis may accelerate targeted treatment of patients with myeloid neoplasms

byElsevierA: Comparison of clinical assay variant allele fraction (VAF) and Ion Torrent Genexus VAF showed high correlation (r2= 0.98) across a broad range of VAFs, including both in-house

Updated on: December 22,2023

Faster genomics-based diagnosis may accelerate targeted treatment of patients with myeloid neoplasms

byElsevierA: Comparison of clinical assay variant allele fraction (VAF) and Ion Torrent Genexus VAF showed high correlation (r2= 0.98) across a broad range of VAFs, including both in-house

Updated on:December 22,2023

Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

byMcGill UniversityCancer cell during cell division. Credit: National Institutes of HealthIt is known that the tumor microenvironment plays an important role in the progression of cancer. But co

Updated on: December 22,2023

Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

byMcGill UniversityCancer cell during cell division. Credit: National Institutes of HealthIt is known that the tumor microenvironment plays an important role in the progression of cancer. But co

Updated on:December 22,2023

High BMI may improve cancer survival

byFlinders UniversityDr. Ganessan Kichenadasse from the Flinders Centre for Innovation in Cancer, South Australia. Credit: Flinders UniversityAbove average or high BMI—often linked to cancers, d

Updated on: December 20,2023

High BMI may improve cancer survival

byFlinders UniversityDr. Ganessan Kichenadasse from the Flinders Centre for Innovation in Cancer, South Australia. Credit: Flinders UniversityAbove average or high BMI—often linked to cancers, d

Updated on:December 20,2023

Using SPEDOX-6 to provide targeted cancer treatment and protect heart cells

by International Society for Stem Cell ResearchSPEDOX-6 causes less damage to heart cells than dox. Left: stem cell derived heart cells treated with dox. Right: stem cell derived heart cells treated w

Updated on: January 04,2024

Using SPEDOX-6 to provide targeted cancer treatment and protect heart cells

by International Society for Stem Cell ResearchSPEDOX-6 causes less damage to heart cells than dox. Left: stem cell derived heart cells treated with dox. Right: stem cell derived heart cells treated w

Updated on:January 04,2024

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo

Updated on: March 20,2024

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo

Updated on:March 20,2024

'Ray of hope': New advances in fighting a range of cancers

Credit: Pixabay/CC0 Public DomainNew advances in the fight against a range of cancers have been revealed at the annual meeting of the American Society of Clinical Oncology (ASCO), which wraps up in Ch

Updated on: January 10,2024

'Ray of hope': New advances in fighting a range of cancers

Credit: Pixabay/CC0 Public DomainNew advances in the fight against a range of cancers have been revealed at the annual meeting of the American Society of Clinical Oncology (ASCO), which wraps up in Ch

Updated on:January 10,2024

Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

by Roswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to hav

Updated on: December 20,2023

Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

by Roswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to hav

Updated on:December 20,2023

Aspirin could reduce ovarian cancer rates for those at higher genetic risk

by Justin Jackson , Medical XpressCredit: Unsplash/CC0 Public DomainA study published inJAMA Network Opensuggests that frequent aspirin use reduces the risk of nonmucinous ovarian cancer,

Updated on: December 18,2023

Aspirin could reduce ovarian cancer rates for those at higher genetic risk

by Justin Jackson , Medical XpressCredit: Unsplash/CC0 Public DomainA study published inJAMA Network Opensuggests that frequent aspirin use reduces the risk of nonmucinous ovarian cancer,

Updated on:December 18,2023

Novel photoacoustic contrast agent offers safer, cost-effective imaging for tumors

Updated on: July 14,2025

Novel photoacoustic contrast agent offers safer, cost-effective imaging for tumors

Updated on:July 14,2025

Improving drug therapy for relapsed leukemia

by Haleigh Ehmsen,Northwestern UniversityResponse rates in all FLT3mutpatients treated at any dose (n = 56) and in those who did (n = 35) or did not (n = 21) receive prior treatment with a

Updated on: December 22,2023

Improving drug therapy for relapsed leukemia

by Haleigh Ehmsen,Northwestern UniversityResponse rates in all FLT3mutpatients treated at any dose (n = 56) and in those who did (n = 35) or did not (n = 21) receive prior treatment with a

Updated on:December 22,2023